A Targeted Personalized Approach
Lantern is disrupting, reinventing and de-risking the traditional cancer drug development process by employing an adaptive “3R strategy” to rescue, reposition and revitalize abandoned drugs by harnessing the power of advanced genomics and artificial intelligence, also applicable for placing new drugs.
Partner With Us
We are a multi-national company committed to technology-driven drug candidate advancement. Join us in this mission.